1Duraker N, Sisman S, Can G. The significance of perineural invasion as a prognostic factor in patients with gastric carcinoma.Surg Today, 2003,33 : 95-100.
2Ayala GE,Dai H,Li R,et al. Bystin in perineural invasion of prostate cancer. Prostate, 2006,66:266-272.
3Hassanein AM, Proper SA, Depcik-Smith ND,et al. Peritumoral fibrosis in basal celland squamous cell carcinoma mimicking perineural invasion: Potential pitfall in mohs micrographic surgery. Dermatol Surg,2005,31 : 1101-1106.
4Chen-Tsai CP, Colome-Grimmer M, Wagner RF Jr. Correlations among neural cell adhesion molecule, nerve growth factor,and its receptors, TrkA, TrkB, TrkC, and p75, in perineural invasion by basal cell and cutaneous squamous cell carcinomas.Dermatol Surg,2004,30:1009-1016.
5Kameda K, Shimada H, Ishikawa T, et al.Expression of highly polysialylated neural cell adhesion molecule in pancreatic cancer neural in vasive lesion. Cancer Lett, 1999,137,201-207.
6Murakawa K, Tada M, Takada M, et al.Prediction of lymph node metastasis andperineural invasion of biliary tract cancer by selected features from cDNA array data. J Surg Res,2004,122:184-194.
7Lee MA, Park GS, Lee HJ, et al. Survivin expression and its clinical significance in pancreatic cancer. BMC Cancer, 2005, 5:127.
8Khan OA,Alexiou C, Soomro I,et al. Pathological determinants of survival in nodenegative oesophageal cancer, Br J Surg,2004,91:1586-1591.
9Giuliani A, Caporale A, Di Bari M, et al.Maximum gastric cancer diameter as a prognostic indicator:Univariate and multivariate analysis. J Exp Clin Cancer Res,2003,22:531-538.
10Fondevila C, Metges JP, Fuster J, et al.p53 and VEGF expression are independent predictors of turnout recurrence and survival following curative resection of gastric cancer. British Journal Of Cancer, 2004,90 : 206-215.
2Vrba L, Jensen TJ, Garbe JC, et al. Role for DNA methylation in the regulation of miR-200c and miR-141 expression in normal and cancer cells. PloS One, 2010, 5 :e8697.
3Song L, Tuan RS. MicroRNAs and cell differentiation in mammalian development. Birth Defects Res C Embryo Today, 2006, 78:140- 149.
4Feber A, Xi L, Luketich JD, et al. MicroRNA expression profiles of esophageal cancer. J Thorac Cardiovasc Surg, 2008, 135 : 255- 260.
5Tong AW, Nemunaitis J. Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy? Cancer Gene Ther, 2008, 15:341-355.
6Petrocca F, Visone R, Onelli MR, et al. E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell, 2008, 13:272-286.
7Landais S, Landry S, Legauh P, et al. Oncogenic potential of the miR-106-363 cluster and its implication in human T-cell leukemia. Cancer Res, 2007, 67:5699-5707.
8Wang Z, Liu M, Zhu H, et al. Suppression of p21 by c-Myc through members of miR-17 family at the post-transcriptional level. Int J Oncol, 2010, 37:1315-1321.
9Xiao B, Guo J, Miao Y, et al. Detection of miR-106a in gastric carcinoma and its clinical significance. Clin Chim Acta, 2009, 400:97-102.
10LinkA, Balaguer F, Shen Y, et al. Fecal MicroRNAs as novel biomarkers for colon cancer screening. Cancer Epidemiol Biomarkers Prey, 2010, 19:1766-1774.
